Tenet Healthcare (NYSE:THC) Stock Rating Lowered by Zacks Research

Posted by Stanley Muller on Oct 1st, 2026

Tenet Healthcare (NYSE:THC – Get Free Report) was downgraded by equities researchers at Zacks Research from a “strong-buy” rating to a “hold” rating in a report issued on Tuesday, Zacks reports.

Several other equities analysts also recently issued reports on THC. TD Cowen raised their price target on shares of Tenet Healthcare from $233.00 to $263.00 and gave the company a “buy” rating in a research note on Monday, July 27th. Mizuho set a $290.00 price objective on Tenet Healthcare in a report on Monday, August 10th. Morgan Stanley raised their target price on Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research report on Monday, July 27th. Wells Fargo & Company upped their price target on Tenet Healthcare from $231.00 to $281.00 and gave the company an “overweight” rating in a research report on Monday, August 3rd. Finally, Truist Financial increased their price target on Tenet Healthcare from $270.00 to $290.00 and gave the company a “buy” rating in a research note on Tuesday, July 28th. Eighteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $277.25.

View Our Latest Analysis on THC

Tenet Healthcare Price Performance

Tenet Healthcare stock opened at $256.06 on Tuesday. The stock has a 50-day moving average price of $260.82 and a two-hundred day moving average price of $214.24. Tenet Healthcare has a 12 month low of $157.58 and a 12 month high of $283.05. The company has a market capitalization of $20.62 billion, a PE ratio of 9.88, a P/E/G ratio of 0.98 and a beta of 1.23. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00.

Tenet Healthcare (NYSE:THC – Get Free Report) last released its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The company had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. During the same quarter in the prior year, the firm posted $4.02 earnings per share. The firm’s revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Analysts expect that Tenet Healthcare will post 21.04 EPS for the current year.

Insiders Place Their Bets

In other Tenet Healthcare news, Director Richard Mark sold 10,000 shares of the company’s stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $263.42, for a total transaction of $2,634,200.00. Following the sale, the director owned 25,121 shares of the company’s stock, valued at approximately $6,617,373.82. This represents a 28.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Lisa Foo sold 24,000 shares of Tenet Healthcare stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $266.32, for a total value of $6,391,680.00. Following the completion of the transaction, the executive vice president directly owned 8,053 shares of the company’s stock, valued at approximately $2,144,674.96. This trade represents a 74.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 131,199 shares of company stock valued at $35,065,587 over the last quarter. Company insiders own 0.97% of the company’s stock.

Institutional Trading of Tenet Healthcare

Large investors have recently modified their holdings of the stock. Manning & Napier Advisors LLC purchased a new position in Tenet Healthcare during the second quarter worth about $168,761,000. Bank of New York Mellon Corp purchased a new stake in Tenet Healthcare in the 2nd quarter valued at about $106,342,000. Boston Partners lifted its position in shares of Tenet Healthcare by 15.7% during the 4th quarter. Boston Partners now owns 3,642,136 shares of the company’s stock worth $723,804,000 after buying an additional 494,581 shares in the last quarter. Allianz Asset Management GmbH grew its holdings in shares of Tenet Healthcare by 78.1% in the fourth quarter. Allianz Asset Management GmbH now owns 868,134 shares of the company’s stock valued at $172,516,000 after acquiring an additional 380,632 shares in the last quarter. Finally, Hsbc Holdings PLC increased its position in shares of Tenet Healthcare by 3,478.7% during the fourth quarter. Hsbc Holdings PLC now owns 266,400 shares of the company’s stock valued at $53,269,000 after acquiring an additional 258,956 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

About Tenet Healthcare

(Get Free Report)

Tenet Healthcare Corporation is a Dallas-based healthcare services company that operates hospitals, outpatient facilities and other healthcare businesses across the United States. Its operations include acute care hospitals, specialty hospitals, ambulatory surgery centers and related outpatient services.

Through its United Surgical Partners International subsidiary, Tenet is one of the major operators and developers of ambulatory surgery centers in the United States. These facilities provide same-day surgical procedures and other outpatient care across a range of medical specialties.